News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cubist Pharmaceuticals, Inc. (CBST) Announces Fourth Quarter/Full-Year 2013 Revenues; Provides Pipeline Update


1/13/2014 7:09:44 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced unaudited fourth quarter and full-year 2013 revenues and a pipeline update as the Company positions itself to achieve its Building Blocks of Growth long-range goals. Cubist delivered 22% total net revenue growth in the fourth quarter compared to 2012, and CUBICINĀ® (daptomycin for injection) achieved blockbuster status with over $1 billion in worldwide sales for the full year.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES